Puma has returned to the trajectory it was on before the COVID-19 pandemic hit.
Puma has returned to the trajectory it was on before the COVID-19 pandemic hit, reporting that revenues leaped 95.8 percent in the second quarter to 1.59 billion euros, and upgrading its outlook for the rest of the year.
Compared to 2019, the last “normal” year for clothing and footwear sales before the health crisis and retail shutdowns began, first-half revenues advanced over 30 percent. The company upgraded its outlook and predicted growth of around 20 percent for the whole year. Previously it had forecast increases in the mid-teens.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Volkswagen posts record first-half earnings and raises profit margin targetVolkswagen posted record first-half earnings on Thursday while also raising its target for profit margin.
Leer más »
3M raises annual forecasts on pandemic recovery, warns of higher costs3M Co (MMM.N) reported a better-than-expected quarterly profit and raised its full-year forecasts, helped by increased demand across major segments as economies recover from the impact of the COVID-19 pandemic.
Leer más »
Intense heat raises the risk of violence in American prisonsAdvocates of prison reform argue that housing inmates in facilities without air conditioning violates the Eighth Amendment, which prohibits “cruel and unusual punishments”
Leer más »
Oil giant Shell raises dividend and launches $2 billion share buyback as commodity prices soarShell boosted its dividend for the second consecutive quarter and announced the launch of a $2 billion share buyback program.
Leer más »
Nissan raises earnings outlook, optimistic chip crunch will easeJapanese automaker Nissan Motor Co (7201.T) on Wednesday raised its earnings outlook for the year, helped by a weaker yen and favourable demand in the United States and China, after reporting a surprise first-quarter operating profit.
Leer más »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter.
Leer más »